CardioGraft-MC® Decellularized Hemi-Pulmonary Artery

CardioGraft-MC®
CardioGraft-MC® Decellularized Hemi-Pulmonary Artery (right or left)
Decellularized human pulmonary artery used for cardiac repair and reconstruction
- Clinical effectiveness – lower potential for reoperation or intervention1,2
- Patented, validated decellularization and disinfection process that removes ≥99% of donor DNA3
- Resists calcification and stenosis1,2
- Allografts most closely resemble native tissue, making them compliant, flexible and easy to handle
-
Potentially reduces operating room time and cost by reducing the rate of serious adverse events and reoperations4
Clinical Application
- Repair of the right ventricular outflow tract for Tetralogy of Fallot
- Truncus Arteriosis
- Hypoplastic Left Heart Syndrome
- Transposition of the Great Arteries
- Pulmonary Stenosis/Atresia
Frozen | Description | Sizing |
---|---|---|
DLHPA | Left | Multiple options, varies by donor |
DRHPA | Right | Multiple options, varies by donor |
References
- Lofland GK, et al. Initial pediatric cardiac experience with decellularized allograft patches. Ann of Thoracic Surg, 2012;93:968-71
- Hopkins RA, et al. Pulmonary Arterioplasty With Decellularized Allogeneic Patches. Ann of Thoracic Surg, Vol. 97, Issue 4, April 2014